{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:34:48Z","timestamp":1780590888733,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["B2014127"],"award-info":[{"award-number":["B2014127"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2010A030400006"],"award-info":[{"award-number":["2010A030400006"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.clinbiochem.2015.07.029","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T14:17:25Z","timestamp":1439648245000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China"],"prefix":"10.1016","volume":"49","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-6169","authenticated-orcid":false,"given":"Chaohui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0005","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0010","first-page":"617","article-title":"An analysis of incidence and mortality for ovarian cancer in China, 2009","volume":"22","author":"Niannian","year":"2013","journal-title":"China Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2015.07.029_bb0015","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajog.2008.12.042","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0025","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2015.07.029_bb0030","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/IGC.0b013e318251ccaa","article-title":"The quest for ovarian cancer screening biomarkers: are we on the right road?","volume":"22","author":"Lokshin","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cca.2012.10.058","article-title":"Detection and monitoring of ovarian cancer","volume":"415","author":"Su","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2014.08.008","article-title":"Abnormal CA-125 levels in menopausal women without ovarian cancer","volume":"135","author":"Terada","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","article-title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","volume":"99","author":"Rosen","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajog.2010.03.043","article-title":"Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass","volume":"203","author":"Moore","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000430858","article-title":"The risk of ovarian malignancy algorithm (ROMA) as a predictive marker of peritoneal dissemination in epithelial ovarian cancer patients","volume":"38","author":"Ikeda","year":"2015","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0100","first-page":"489","article-title":"Factors influencing serum CA125II levels in healthy postmenopausal women","volume":"10","author":"Pauler","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.11.013","article-title":"Development of a multi-marker assay for differential diagnosis of benign and malignant pelvic masses","volume":"440","author":"Chen","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0110","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0115","first-page":"1191","article-title":"The research on the factors affecting the timing of natural menopause in Chinese city women","volume":"26","author":"Chanshou","year":"2011","journal-title":"Matern. Child Health Care China"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0120","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","article-title":"Human epididymis protein 4 (HE4) in benign and malignant diseases","volume":"50","author":"Hertlein","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwn006","article-title":"Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women","volume":"167","author":"Moorman","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/CCLM.2011.085","article-title":"Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case\u2013control study in a Korean population","volume":"49","author":"Kim","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0140","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1515\/CCLM.2011.709","article-title":"The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses","volume":"49","author":"Lenhard","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0145","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0150","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cca.2011.04.028","article-title":"HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm","volume":"412","author":"Ruggeri","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0165","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","article-title":"Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma","volume":"21","author":"Chang","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0170","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1200\/JCO.2005.08.151","article-title":"Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study","volume":"23","author":"Paramasivam","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0175","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.7314\/APJCP.2014.15.5.1949","article-title":"Modification of cutoff values for HE4, CA125, the Risk of Malignancy Index, and the Risk of Malignancy Algorithm for ovarian cancer detection in Jakarta, Indonesia","volume":"15","author":"Winarto","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.clinbiochem.2015.07.029_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015003094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015003094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:09:08Z","timestamp":1762114148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0009912015003094"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.029","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}